VCAM1 and atherosclerosis: Antibodies against vascular cell adhesion molecule (VCAM)-1 represent an attractive strategy for atherosclerosis and cardiovascular disease management due to their ability to selectively block leukocyte-endothelial interactions involved in inflammatory cell recruitment.